Two such genes, the amyloid-beta precursor protein (APP) and the inositol-trisphosphate 3-kinase B (ITPKB), have multiple AP–1 sites and their dysregulation has been strongly implicated in AD progression [15,16]. This evidence concerns the gene JUN and Alzheimer disease.